BD Announces First Fiscal Quarter Results; Raises Fiscal 2021 Guidance
- First fiscal quarter revenues of $5.315 billion grew 25.8% on a reported basis. On a currency-neutral basis, revenues increased 24.3%.
- BD s COVID-19 testing sales of $867 million contributed 20.5 percentage points to revenue growth on a reported basis. This includes BD Veritor™ Plus System revenues of $688 million.
- First fiscal quarter GAAP diluted earnings per share (EPS) increased 285% year-over-year to $3.35.
- Adjusted EPS increased 71.7% year-over-year to $4.55.
- BD is updating its fiscal 2021 guidance, including raising its fiscal 2021 adjusted EPS guidance to $12.75-$12.85.
News provided by
Share this article
Share this article
FRANKLIN LAKES, N.J., Feb. 4, 2021 /PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $5.315 billion for the first fiscal quarter ended December 31, 2020. This represents
FRANKLIN LAKES, N.J., Jan. 12, 2021 /PRNewswire/ BD , a leading global medical technology company, today reported, preliminary unaudited financial information for the first fiscal. | January 16, 2021